- Home
- RANI vs MAPS Comparison
RANI vs MAPS Comparison
Compare RANI & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- MAPS
- Stock Information
- Founded
- RANI 2012
- MAPS 2008
- Country
- RANI United States
- MAPS United States
- Employees
- RANI N/A
- MAPS N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- MAPS Computer Software: Prepackaged Software
- Sector
- RANI Health Care
- MAPS Technology
- Exchange
- RANI Nasdaq
- MAPS Nasdaq
- Market Cap
- RANI 78.3M
- MAPS 84.2M
- IPO Year
- RANI 2021
- MAPS N/A
- Fundamental
- Price
- RANI $2.35
- MAPS $0.99
- Analyst Decision
- RANI Strong Buy
- MAPS Buy
- Analyst Count
- RANI 5
- MAPS 2
- Target Price
- RANI $11.80
- MAPS $2.61
- AVG Volume (30 Days)
- RANI 832.6K
- MAPS 849.4K
- Earning Date
- RANI 11-14-2024
- MAPS 11-12-2024
- Dividend Yield
- RANI N/A
- MAPS N/A
- EPS Growth
- RANI N/A
- MAPS N/A
- EPS
- RANI N/A
- MAPS N/A
- Revenue
- RANI N/A
- MAPS $183,311,000.00
- Revenue This Year
- RANI N/A
- MAPS N/A
- Revenue Next Year
- RANI N/A
- MAPS $9.09
- P/E Ratio
- RANI N/A
- MAPS N/A
- Revenue Growth
- RANI N/A
- MAPS N/A
- 52 Week Low
- RANI $1.90
- MAPS $0.70
- 52 Week High
- RANI $8.75
- MAPS $1.47
- Technical
- Relative Strength Index (RSI)
- RANI 47.17
- MAPS 66.94
- Support Level
- RANI $2.32
- MAPS $0.71
- Resistance Level
- RANI $2.67
- MAPS $0.84
- Average True Range (ATR)
- RANI 0.17
- MAPS 0.06
- MACD
- RANI 0.01
- MAPS 0.02
- Stochastic Oscillator
- RANI 34.02
- MAPS 99.00
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.